Sign in

CIK 0000875320

  • Large accelerated filer

VERTEX PHARMACEUTICALS INC / MA

Sign in to watch
Ticker
VRTX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
MA
Entity type
Operating
EIN
043039129
Phone
+1 617-341-6393
Business address
50 NORTHERN AVENUE, BOSTON, MA, 02210
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$15,378,206
in 4 filings, $15.4M under 10b5-1 plans

Net −$15,378,206. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2024-02-06 Biller Jonathan EVP and Chief Legal Officer Grant or award +6,294 16,863
2024-02-06 Atkinson Edward Morrow III EVP, Chief Technical Ops. Off. Grant or award +2,326 16,205
2024-02-06 Atkinson Edward Morrow III EVP, Chief Technical Ops. Off. Grant or award +3,934 20,139
2024-02-06 Arbuckle Stuart A EVP, COO Grant or award +6,976 63,532
2024-02-06 Arbuckle Stuart A EVP, COO Grant or award +11,210 74,742
2024-02-06 Ambrose Kristen SVP & Chief Accounting Officer Grant or award +2,950 9,788
2024-02-06 ALTSHULER DAVID EVP, Global Research and CSO Grant or award +5,814 37,852
2024-02-06 ALTSHULER DAVID EVP, Global Research and CSO Grant or award +7,866 45,718
2024-01-12 SACHS BRUCE I Director Grant or award · Deferred Stock Units +101.04 $432.99 $44K 14,744.26
2024-01-12 MCKENZIE DIANA Director Grant or award · Deferred Stock Units +76.5 $432.99 $33K 4,822.48
2024-01-08 LEIDEN JEFFREY M Executive Chairman Sale 10b5-1 −6,648 $419.07 $2.8M 2,423
2024-01-02 WAGNER CHARLES F JR EVP & Chief Financial Officer Sale 10b5-1 −3,000 $405.00 $1.2M 43,693
2023-12-15 Kewalramani Reshma CEO & President Exercise or conversion 10b5-1 +3,058 $155.57 $476K 111,769
2023-12-15 Kewalramani Reshma CEO & President Exercise or conversion 10b5-1 +14,077 $187.53 $2.6M 125,846
2023-12-15 Kewalramani Reshma CEO & President Sale 10b5-1 −17,135 $407.00 $7.0M 108,711
2023-12-15 Kewalramani Reshma CEO & President Exercise or conversion · Stock Option (Right to Buy) 10b5-1 −3,058 0
2023-12-15 Kewalramani Reshma CEO & President Exercise or conversion · Stock Option (Right to Buy) 10b5-1 −14,077 1,565
2023-12-13 LEIDEN JEFFREY M Executive Chairman Sale 10b5-1 −13,254 $399.41 $5.3M 9,171
2023-12-13 LEIDEN JEFFREY M Executive Chairman Sale 10b5-1 −100 $400.19 $40K 9,071
2023-12-13 Kewalramani Reshma CEO & President Sale 10b5-1 −5,098 $397.00 $2.0M 108,711

Page 26 of 27 · 524 trades